Literature DB >> 20213538

A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets.

Ryusuke Koshida1, Hideki Yamaguchi, Koji Yamasaki, Wakaba Tsuchimochi, Tadato Yonekawa, Masamitsu Nakazato.   

Abstract

Autosomal recessive hypophosphatemic rickets (ARHR) is an extremely rare disorder of autosomal recessive inheritance, characterized by hypophosphatemia resulting from renal phosphate wasting. Dentin matrix protein 1 (DMP1), a noncollagenous extracellular protein, plays critical roles in bone mineralization and phosphate homeostasis. Recently, loss-of-function mutations in DMP1 gene have been identified as the molecular cause of ARHR. Here, we describe a Japanese family that includes two ARHR-affected siblings carrying a novel mutation of the DMP1 gene. The patients were a 53-year-old woman and a 50-year-old man with short stature and skeletal deformities who were the offspring of a first-cousin marriage. Biochemical examination revealed hypophosphatemia with renal phosphate excretion and low levels of 1,25(OH)(2)D. Serum calcium, parathyroid hormone, and urinary calcium excretion were within the normal range, leading to clinical diagnosis of ARHR. Sequence analysis of peripheral leukocytes from the patients revealed that they carried a novel homozygous nonsense mutation in the DMP1 gene (98G>A, W33X), which leads to a truncated DMP protein with no putative biological function. Unaffected family members were heterozygous for the mutation. This is the first report of a Japanese family with ARHR carrying a novel mutation of the DMP1 gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213538     DOI: 10.1007/s00774-010-0169-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  25 in total

1.  Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1.

Authors:  Gen He; Tom Dahl; Arthur Veis; Anne George
Journal:  Nat Mater       Date:  2003-08       Impact factor: 43.841

Review 2.  Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.

Authors:  Lynne E Maquat
Journal:  Nat Rev Mol Cell Biol       Date:  2004-02       Impact factor: 94.444

3.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

Authors:  Yuji Yamazaki; Ryo Okazaki; Minako Shibata; Yukihiro Hasegawa; Kohei Satoh; Toshihiro Tajima; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Takeyoshi Yamashita; Seiji Fukumoto
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

4.  Phenotypic variation in dentinogenesis imperfecta/dentin dysplasia linked to 4q21.

Authors:  M L Beattie; J-W Kim; S-G Gong; C A Murdoch-Kinch; J P Simmer; J C-C Hu
Journal:  J Dent Res       Date:  2006-04       Impact factor: 6.116

5.  Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization.

Authors:  A George; B Sabsay; P A Simonian; A Veis
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

6.  A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.

Authors:  Tobias Larsson; Xijie Yu; Siobhan I Davis; Mohamad S Draman; Sean D Mooney; Michael J Cullen; Kenneth E White
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

7.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  Dentin matrix protein 1 regulates dentin sialophosphoprotein gene transcription during early odontoblast differentiation.

Authors:  Karthikeyan Narayanan; Sivakumar Gajjeraman; Amsaveni Ramachandran; Jianjun Hao; Anne George
Journal:  J Biol Chem       Date:  2006-05-05       Impact factor: 5.157

9.  A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.

Authors:  Kaori Araya; Seiji Fukumoto; Rebecca Backenroth; Yasuhiro Takeuchi; Kounosuke Nakayama; Nobuaki Ito; Nozomi Yoshii; Yuji Yamazaki; Takeyoshi Yamashita; Justin Silver; Takashi Igarashi; Toshiro Fujita
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

10.  Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

Authors:  Itsuro Endo; Seiji Fukumoto; Keiichi Ozono; Noriyuki Namba; Hiroyuki Tanaka; Daisuke Inoue; Masanori Minagawa; Toshitsugu Sugimoto; Mika Yamauchi; Toshimi Michigami; Toshio Matsumoto
Journal:  Bone       Date:  2008-03-05       Impact factor: 4.398

View more
  16 in total

1.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

Review 2.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 3.  Genetics of Refractory Rickets: Identification of Novel PHEX Mutations in Indian Patients and a Literature Update.

Authors:  Binata Marik; Arvind Bagga; Aditi Sinha; Pankaj Hari; Arundhati Sharma
Journal:  J Pediatr Genet       Date:  2018-01-28

4.  Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.

Authors:  Mary D Ruppe; Patrick G Brosnan; Kit Sing Au; Phong X Tran; Barbara W Dominguez; Hope Northrup
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

Review 5.  Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?

Authors:  Michael P Whyte; S Deepak Amalnath; William H McAlister; Marc D McKee; Deborah J Veis; Margaret Huskey; Shenghui Duan; Vinieth N Bijanki; Suhas Alur; Steven Mumm
Journal:  Bone       Date:  2019-12-13       Impact factor: 4.398

6.  Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.

Authors:  Yinshi Ren; Xianglong Han; Yan Jing; Baozhi Yuan; Huazhu Ke; Min Liu; Jian Q Feng
Journal:  Matrix Biol       Date:  2015-12-22       Impact factor: 11.583

Review 7.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

8.  The LPV Motif Is Essential for the Efficient Export of Secretory DMP1 From the Endoplasmic Reticulum.

Authors:  Tian Liang; Tian Meng; Suzhen Wang; Chunlin Qin; Yongbo Lu
Journal:  J Cell Physiol       Date:  2015-12-14       Impact factor: 6.384

Review 9.  Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

Authors:  Jian Q Feng; Erica L Clinkenbeard; Baozhi Yuan; Kenneth E White; Marc K Drezner
Journal:  Bone       Date:  2013-02-09       Impact factor: 4.398

10.  Constitutive nuclear expression of dentin matrix protein 1 fails to rescue the Dmp1-null phenotype.

Authors:  Shuxian Lin; Qi Zhang; Zhengguo Cao; Yongbo Lu; Hua Zhang; Kevin Yan; Ying Liu; Marc D McKee; Chunlin Qin; Zhi Chen; Jian Q Feng
Journal:  J Biol Chem       Date:  2014-06-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.